< Back to search trials

TRITON 3: A Multicenter, Randomized, Open-label Phase 3 Study of Rucaparib versus Physician’s Choice of Therapy for Patients with Metastatic Castration-resistant Prostate Cancer Associated with Homologous Recombination Deficiency

  • Clinicaltrials.gov #: NCT02975934
  • Acronym: CO-338-063 / TRITON 3
  • Tumor Type: Genitourinary
  • Tumor Subtype: Prostate Cancer
  • Tumor Stage: N/A
  • Type of Treatment: